Peripheral/Endo

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)

COMPASS open label extension study results support the long-term use of XARELTO® plus aspirin for vascular protection in patients with chronic CAD and/or PAD XATOA registry provides further evidence of the benefit of DPI for CAD and/or PAD patients at high risk of cardiovascular (CV) events RARITAN, N.J., May 23, 2022 /PRNewswire/ — Findings from […]

Shockwave Medical and Genesis MedTech Obtain Regulatory Approval in China for Intravascular Lithotripsy

Approvals Cover Both Coronary and Peripheral IVL Catheters and Generators Manufactured by Shockwave SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, and Genesis MedTech Group announced today that […]

VenoStent Technology Receives Breakthrough Device Designation by FDA

HOUSTON, TX / ACCESSWIRE / May 17, 2022 / VenoStent, Inc., a clinical-stage tissue engineering company developing bioabsorbable perivascular wraps to improve outcomes in the 5 million vascular surgeries performed each year, announces that The Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration (FDA) has granted […]

Centerline Biomedical Announces Successful Structural Heart Animal Study

Centerline Biomedical executes animal study demonstrating 4D augmented reality navigation through complex structures of the heart CLEVELAND , May 19, 2022 /PRNewswire/ — Centerline Biomedical, Inc. (Centerline) announced Thursday the completion of the second in a series of structural heart navigation animal studies. Physicians from Cleveland Clinic’s top-ranked Heart, Vascular and Thoracic Institute […]

Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years

Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today […]

According to THE SAGE GROUP, Gender is a Significant Factor in African American (AA) Peripheral Artery Disease (PAD) Disparities

BEAUFORT, S.C.–(BUSINESS WIRE)–Research published by THE SAGE GROUP examines PAD disparities in African Americans and the contributing factors, as well as quantifies PAD prevalence in AA. “While it is well known that African Americans have a higher prevalence of PAD, prior to this publication, there were no estimates of the […]

Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device

WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA® Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access […]

SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock (AMICS) patients during the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 Scientific Sessions, May 19 […]

Stents With Torsional Strength for Superficial Femoral Artery Disease: The Prospective Q3-Registry

Q3 Medical Devices Bi-Directional Stent, QualiMed Innovative Medizinprodukte GmbH, Winsen, Germany Results Published DUBLIN, May 17, 2022 /PRNewswire/ — Journal of Endovascular Therapy, 2022 (Impact factor 3.487 source Sage Journals) with title “Stents with torsional strength for Superficial Femoral artery disease. The prospective Q3-Registry” by Thieme et al: “The Q3 SELF-EXPANDING stent offers a novel patented Bi-Directional design providing for a new way of flexibility and torsional conformability that is highly durable and crush resistant working in unison […]

Enrollment Completed in Reflow Medical’s DEEPER OUS Clinical Trial

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announces that it has completed patient enrollment in the DEEPER OUS clinical trial (NCT03807531) for the company’s Temporary Spur Stent System, a novel device that features a retrievable stent designed for complex infrapopliteal disease. 106 patients have now been enrolled in the prospective, nonrandomized […]